It reduces circulating activated granulocytes and monocytes, leading to decreased pro-inflammatory cytokines such as TNF-α and IL-1, as demonstrated in rheumatoid arthritis, psoriasis, and pyoderma gangrenosum. The gene discussed is TNF; the disease is rheumatoid arthritis.